Search research articles
Contact Us
Filters
Showing results (41-50 of 45) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 45 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 16, 2022
Clonal KEAP1 mutations with loss of heterozygosity share reduced immunotherapy efficacy and low immune cell infiltration in lung adenocarcinoma
S Scalera, B Ricciuti, M Mazzotta, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 25, 2022
Dissecting the clinicopathologic, genomic, and immunophenotypic correlates of KRAS<sup>G12D</sup>-mutated non-small-cell lung cancer
B Ricciuti, J V Alessi, A Elkrief, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 16, 2019
EGFR mutation subtypes and response to immune checkpoint blockade treatment in non-small-cell lung cancer
K Hastings, H A Yu, W Wei, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 17, 2022
Oncology clinical trial disruption during the COVID-19 pandemic: a COVID-19 and cancer outcomes study
Z Bakouny, C Labaki, S Bhalla, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 5, 2024
Lung adenocarcinomas with mucinous histology: clinical, genomic, and immune microenvironment characterization and outcomes to immunotherapy-based treatments and KRAS<sup>G12C</sup> inhibitors
A Di Federico, L Hong, A Elkrief, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 45) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 45 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 16, 2022
Clonal KEAP1 mutations with loss of heterozygosity share reduced immunotherapy efficacy and low immune cell infiltration in lung adenocarcinoma
S Scalera, B Ricciuti, M Mazzotta, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 25, 2022
Dissecting the clinicopathologic, genomic, and immunophenotypic correlates of KRAS<sup>G12D</sup>-mutated non-small-cell lung cancer
B Ricciuti, J V Alessi, A Elkrief, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 16, 2019
EGFR mutation subtypes and response to immune checkpoint blockade treatment in non-small-cell lung cancer
K Hastings, H A Yu, W Wei, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 17, 2022
Oncology clinical trial disruption during the COVID-19 pandemic: a COVID-19 and cancer outcomes study
Z Bakouny, C Labaki, S Bhalla, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 5, 2024
Lung adenocarcinomas with mucinous histology: clinical, genomic, and immune microenvironment characterization and outcomes to immunotherapy-based treatments and KRAS<sup>G12C</sup> inhibitors
A Di Federico, L Hong, A Elkrief, et al.
Page
of 5